Everolimus sensitizes Ras-transformed cells to radiation in vitro through the autophagy pathway

Yu Chieh Su, Chih Chia Yu, Fei Ting Hsu, Shu Ling Fu, Jeng Jong Hwang, Ling Chien Hung, Moon Sing Lee, Wen Yen Chiou, Hon Yi Lin, Shih Kai Hung

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Modern radiation therapy strives to minimize injury to organs while increasing the anticancer effects. The present study aimed to investigate the radiosensitizing effects of everolimus and to examine the molecular mechanisms responsible for everolimus-mediated radiosensitization. Radiation in combination with everolimus (30 nM) sensitized Ras-transformed cells to radiation in vitro. Radiation induced apoptotic markers (sub-G1 cell accumulation, membrane inversion and DNA fragmentation) and treatment with everolimus did not promote radiation-induced apoptosis. However, LC3-II expression increased following combination treatment with everolimus and radiation, and the radiosensitizing effects of everolimus were reversed following transfection with small interfering RNA (siRNA) targeting Beclin 1. In addition, the protein levels of activated S6 kinase 1 (S6K1) were significantly reduced following treatment with everolimus, and the phosphorylation of factor 4E binding protein 1 (4EBP1) was suppressed following combination treatment. Taken together, our data demonstrate that everolimus sensitizes Ras-transformed cells to radiation in vitro. Everolimus-mediated radiosensitization is associated with the autophagy pathway. Thus, everolimus is a novel radiosensitizing agent with potential for use in cancer radiotherapy.

Original languageEnglish
Pages (from-to)1417-1422
Number of pages6
JournalInternational Journal of Molecular Medicine
Volume34
Issue number5
DOIs
Publication statusPublished - Nov 1 2014
Externally publishedYes

Fingerprint

Autophagy
Radiation
Radiation-Sensitizing Agents
Radiotherapy
Everolimus
In Vitro Techniques
Ribosomal Protein S6 Kinases
Radiation Effects
DNA Fragmentation
Therapeutics
Small Interfering RNA
Transfection
Carrier Proteins
Phosphorylation
Cell Membrane
Apoptosis

Keywords

  • Autophagy
  • Everolimus
  • Radiosensitization
  • Ras

ASJC Scopus subject areas

  • Genetics
  • Medicine(all)

Cite this

Su, Y. C., Yu, C. C., Hsu, F. T., Fu, S. L., Hwang, J. J., Hung, L. C., ... Hung, S. K. (2014). Everolimus sensitizes Ras-transformed cells to radiation in vitro through the autophagy pathway. International Journal of Molecular Medicine, 34(5), 1417-1422. https://doi.org/10.3892/ijmm.2014.1927

Everolimus sensitizes Ras-transformed cells to radiation in vitro through the autophagy pathway. / Su, Yu Chieh; Yu, Chih Chia; Hsu, Fei Ting; Fu, Shu Ling; Hwang, Jeng Jong; Hung, Ling Chien; Lee, Moon Sing; Chiou, Wen Yen; Lin, Hon Yi; Hung, Shih Kai.

In: International Journal of Molecular Medicine, Vol. 34, No. 5, 01.11.2014, p. 1417-1422.

Research output: Contribution to journalArticle

Su, YC, Yu, CC, Hsu, FT, Fu, SL, Hwang, JJ, Hung, LC, Lee, MS, Chiou, WY, Lin, HY & Hung, SK 2014, 'Everolimus sensitizes Ras-transformed cells to radiation in vitro through the autophagy pathway', International Journal of Molecular Medicine, vol. 34, no. 5, pp. 1417-1422. https://doi.org/10.3892/ijmm.2014.1927
Su, Yu Chieh ; Yu, Chih Chia ; Hsu, Fei Ting ; Fu, Shu Ling ; Hwang, Jeng Jong ; Hung, Ling Chien ; Lee, Moon Sing ; Chiou, Wen Yen ; Lin, Hon Yi ; Hung, Shih Kai. / Everolimus sensitizes Ras-transformed cells to radiation in vitro through the autophagy pathway. In: International Journal of Molecular Medicine. 2014 ; Vol. 34, No. 5. pp. 1417-1422.
@article{b068000c6c0b4885a80b94e0f392c1ca,
title = "Everolimus sensitizes Ras-transformed cells to radiation in vitro through the autophagy pathway",
abstract = "Modern radiation therapy strives to minimize injury to organs while increasing the anticancer effects. The present study aimed to investigate the radiosensitizing effects of everolimus and to examine the molecular mechanisms responsible for everolimus-mediated radiosensitization. Radiation in combination with everolimus (30 nM) sensitized Ras-transformed cells to radiation in vitro. Radiation induced apoptotic markers (sub-G1 cell accumulation, membrane inversion and DNA fragmentation) and treatment with everolimus did not promote radiation-induced apoptosis. However, LC3-II expression increased following combination treatment with everolimus and radiation, and the radiosensitizing effects of everolimus were reversed following transfection with small interfering RNA (siRNA) targeting Beclin 1. In addition, the protein levels of activated S6 kinase 1 (S6K1) were significantly reduced following treatment with everolimus, and the phosphorylation of factor 4E binding protein 1 (4EBP1) was suppressed following combination treatment. Taken together, our data demonstrate that everolimus sensitizes Ras-transformed cells to radiation in vitro. Everolimus-mediated radiosensitization is associated with the autophagy pathway. Thus, everolimus is a novel radiosensitizing agent with potential for use in cancer radiotherapy.",
keywords = "Autophagy, Everolimus, Radiosensitization, Ras",
author = "Su, {Yu Chieh} and Yu, {Chih Chia} and Hsu, {Fei Ting} and Fu, {Shu Ling} and Hwang, {Jeng Jong} and Hung, {Ling Chien} and Lee, {Moon Sing} and Chiou, {Wen Yen} and Lin, {Hon Yi} and Hung, {Shih Kai}",
year = "2014",
month = "11",
day = "1",
doi = "10.3892/ijmm.2014.1927",
language = "English",
volume = "34",
pages = "1417--1422",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Everolimus sensitizes Ras-transformed cells to radiation in vitro through the autophagy pathway

AU - Su, Yu Chieh

AU - Yu, Chih Chia

AU - Hsu, Fei Ting

AU - Fu, Shu Ling

AU - Hwang, Jeng Jong

AU - Hung, Ling Chien

AU - Lee, Moon Sing

AU - Chiou, Wen Yen

AU - Lin, Hon Yi

AU - Hung, Shih Kai

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Modern radiation therapy strives to minimize injury to organs while increasing the anticancer effects. The present study aimed to investigate the radiosensitizing effects of everolimus and to examine the molecular mechanisms responsible for everolimus-mediated radiosensitization. Radiation in combination with everolimus (30 nM) sensitized Ras-transformed cells to radiation in vitro. Radiation induced apoptotic markers (sub-G1 cell accumulation, membrane inversion and DNA fragmentation) and treatment with everolimus did not promote radiation-induced apoptosis. However, LC3-II expression increased following combination treatment with everolimus and radiation, and the radiosensitizing effects of everolimus were reversed following transfection with small interfering RNA (siRNA) targeting Beclin 1. In addition, the protein levels of activated S6 kinase 1 (S6K1) were significantly reduced following treatment with everolimus, and the phosphorylation of factor 4E binding protein 1 (4EBP1) was suppressed following combination treatment. Taken together, our data demonstrate that everolimus sensitizes Ras-transformed cells to radiation in vitro. Everolimus-mediated radiosensitization is associated with the autophagy pathway. Thus, everolimus is a novel radiosensitizing agent with potential for use in cancer radiotherapy.

AB - Modern radiation therapy strives to minimize injury to organs while increasing the anticancer effects. The present study aimed to investigate the radiosensitizing effects of everolimus and to examine the molecular mechanisms responsible for everolimus-mediated radiosensitization. Radiation in combination with everolimus (30 nM) sensitized Ras-transformed cells to radiation in vitro. Radiation induced apoptotic markers (sub-G1 cell accumulation, membrane inversion and DNA fragmentation) and treatment with everolimus did not promote radiation-induced apoptosis. However, LC3-II expression increased following combination treatment with everolimus and radiation, and the radiosensitizing effects of everolimus were reversed following transfection with small interfering RNA (siRNA) targeting Beclin 1. In addition, the protein levels of activated S6 kinase 1 (S6K1) were significantly reduced following treatment with everolimus, and the phosphorylation of factor 4E binding protein 1 (4EBP1) was suppressed following combination treatment. Taken together, our data demonstrate that everolimus sensitizes Ras-transformed cells to radiation in vitro. Everolimus-mediated radiosensitization is associated with the autophagy pathway. Thus, everolimus is a novel radiosensitizing agent with potential for use in cancer radiotherapy.

KW - Autophagy

KW - Everolimus

KW - Radiosensitization

KW - Ras

UR - http://www.scopus.com/inward/record.url?scp=84907187798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907187798&partnerID=8YFLogxK

U2 - 10.3892/ijmm.2014.1927

DO - 10.3892/ijmm.2014.1927

M3 - Article

VL - 34

SP - 1417

EP - 1422

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 5

ER -